Angiodynamics Inc

Ownership Transactions Reported by 17 Insiders

Symbol
ANGO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
14 Plaza Drive, Latham, NY

Insiders trading volume in the past year

Angiodynamics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James C. Clemmer President and CEO, Director $4.11M +$188K +4.78% Oct 7, 2024
Dennis S. Meteny Director $1.21M Jul 19, 2023
Stephen A. Trowbridge EVP and CFO $1.01M +$9.96K +0.99% Oct 8, 2024
Howard W. Donnelly Director $1M Jul 17, 2024
Wesley Johnson Director $843K Jul 17, 2024
Jan Stern Reed Director $585K Jul 17, 2024
Eileen O'Shea Auen Director $583K Jul 17, 2024
Scott Centea Svp/Gm, Vit $545K Jul 20, 2023
Karen A. Licitra Director $487K Jul 17, 2024
Chad Thomas Campbell SVP/GM, Vascular Access $453K Jul 20, 2024
Michael E. Tarnoff Director $440K Jul 17, 2024
Lawrence Weiss SVP, Chief Legal Officer $320K Dec 2, 2024
Dave Helsel SVP Global Operations and R&D $298K Jul 20, 2023
Warren Nighan JR SVP Quality and Regulatory $279K +$5.29K +1.93% Oct 7, 2024
Laura Piccinini SVP International $271K Jul 20, 2024
Lorinda Burgess Director $252K Jul 17, 2024
Richard C. Rosenzweig SVP and General Counsel $136K Feb 1, 2023

Recent Insider Transactions by Companies or Individuals for Angiodynamics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.